Brussels, 21 May 2025

EuropaBio welcomes the publication of the Single Market Strategy by the European Commission and its ambition to remove key barriers, strengthen SME participation, and accelerate digitalisation across the EU. The Strategy sets a renewed course for a more integrated, competitive, and resilient Single Market.

Biotechnology is central to Europe’s economic resilience, sustainability, and health preparedness. The Strategy’s focus on simplification, regulatory coherence, and SME support provides an opportunity to better integrate biotechnology into Europe’s broader policy framework.  Without targeted support for high-impact sectors like biotech, the Strategy risks missing key drivers of innovation-led growth.

In its consultation response, EuropaBio called for regulatory harmonisation, stronger intellectual property protections, and tailored measures for biotech SMEs through an ambitious EU Biotech Act.

Dr. Claire Skentelbery, Director General of EuropaBio, said: “The Strategy sets the right foundations, and Europe must now act with focus and urgency. Ambitious support for biotechnology will be crucial to deliver Single Market success.”

EuropaBio remains committed to supporting a strong Single Market that enables biotech innovation, reduces fragmentation, and secures Europe’s global leadership in the bioeconomy.